Literature DB >> 17717199

Overexpression of GATA-3 protects against the development of hypersensitivity pneumonitis.

Yosuke Matsuno1, Yukio Ishii, Keigyou Yoh, Yuko Morishima, Norihiro Haraguchi, Norihiro Kikuchi, Takashi Iizuka, Takumi Kiwamoto, Shinsuke Homma, Akihiro Nomura, Tohru Sakamoto, Morio Ohtsuka, Nobuyuki Hizawa, Satoru Takahashi.   

Abstract

RATIONALE: Hypersensitivity pneumonitis (HP) is mediated by a Th1 immune response. Transcription factor GATA binding protein-3 (GATA-3) is believed to be a key regulator of Th2 differentiation and thus might play regulatory roles in the pathogenesis of hypersensitivity pneumonitis (HP).
OBJECTIVES: We examined the effect of GATA-3 overexpression on the development of HP in mice.
METHODS: Wild-type C57BL/6 mice and GATA-3-overexpressing mice of the same background were used in this study. HP was induced by repeated exposure to Saccharopolyspora rectivirgula, the causative antigen of farmer's lung.
MEASUREMENTS AND MAIN RESULTS: Antigen exposure resulted in a marked inflammatory response with enhanced pulmonary expression of T-bet and the Th1 cytokine interferon (IFN)-gamma in wild-type mice. The degree of pulmonary inflammation was much less severe in GATA-3-overexpressing mice. The induction of T-bet and IFN-gamma genes was suppressed, but a significant induction of Th2 cytokines, including IL-5 and IL-13, was observed in the lungs of GATA-3-overexpressing mice after antigen exposure. Supplementation with recombinant IFN-gamma enhanced lung inflammatory responses in GATA-3-overexpressing mice to the level of wild-type mice. Because antigen-induced IFN-gamma production predominantly occurred in CD4+ T cells, nude mice were transferred with CD4+ T cells from either wild-type or GATA-3-overexpressing mice and subsequently exposed to antigen. Lung inflammatory responses were significantly lower in nude mice transferred with CD4+ T cells from GATA-3-overexpressing mice than in those with wild-type CD4+ T cells, with a reduction of lung IFN-gamma level.
CONCLUSIONS: These results indicate that overexpression of GATA-3 attenuates the development of HP by correcting the Th1-polarizing condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717199     DOI: 10.1164/rccm.200612-1887OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

Review 1.  Transgenic modelling of cytokine polarization in the lung.

Authors:  Charles S Dela Cruz; Min-Jong Kang; Won-Kyung Cho; Chun Geun Lee
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  Molecular cloning of grass carp (Ctenopharyngodon idellus) T-bet and GATA-3, and their expression profiles with IFN-γ in response to grass carp reovirus (GCRV) infection.

Authors:  Lu Wang; Na Shang; Hong Feng; Qionglin Guo; Heping Dai
Journal:  Fish Physiol Biochem       Date:  2012-10-30       Impact factor: 2.794

3.  Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis.

Authors:  Daniel J Fong; Cory M Hogaboam; Yosuke Matsuno; Shizuo Akira; Satoshi Uematsu; Amrita D Joshi
Journal:  Immunology       Date:  2010-01-11       Impact factor: 7.397

4.  TLR2 regulates neutrophil recruitment and cytokine production with minor contributions from TLR9 during hypersensitivity pneumonitis.

Authors:  Kelly Andrews; Hossam Abdelsamed; Ae-Kyung Yi; Mark A Miller; Elizabeth A Fitzpatrick
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

5.  Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice.

Authors:  Keigyou Yoh; Masami Ojima; Satoru Takahashi
Journal:  Exp Anim       Date:  2015-07-06

6.  T-bet, but not Gata3, overexpression is detrimental in a neurotropic viral infection.

Authors:  Fumitaka Sato; Eiichiro Kawai; Nicholas E Martinez; Seiichi Omura; Ah-Mee Park; Satoru Takahashi; Keigyou Yoh; Ikuo Tsunoda
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.